DLA Piper has advised the sponsors and the underwriters of the Chinese healthcare platform 160 Health International Limited (160 Health) on its Initial Public Offering (IPO) on the Main Board of the Hong Kong Stock Exchange (HKEX), which raised approximately HKD 400 million. The company commenced trading today, 17 September 2025. Shenwan Hongyuan Capital (H.K.) Limited and Zero2IPO Capital Limited are the Joint Sponsors.
160 Health is an experienced pharmaceutical and healthcare product wholesaler and a leading digital healthcare integrated service provider in China. Through its Healthcare 160 platform, which is recognised as the largest digital healthcare and wellness service platform in the digital healthcare integrated service industry in China, it delivers comprehensive digital healthcare and wellness solutions to a broad network of participants – including businesses, medical institutions, professionals, individual users, and third-party merchants – supporting the digital transformation of China’s healthcare value chain.
The DLA Piper team was led by George Wu, partner and Co-Head of Equity Capital Markets EMEA and Asia Pacific, with support in Hong Kong from senior associate Jack Li, registered foreign lawyers Jessica Sun and Yu Sun, associate Marcus Ng, legal officer Ivy Chung, legal assistants Nicholas Chan, Lily Choi and trainee solicitor Bernie Wong. Additional support was provided by legal assistant Charlotte Wang in Shanghai and Corporate associate Sophia Sun from Shanghai Kaiman Law Firm.
Commenting on the listing George said: “160 Health’s successful listing reflects both the company’s strong fundamentals and the exciting growth potential of China’s rapidly evolving digital healthcare sector. Our team is proud to have supported our client on this significant milestone, which not only highlights the strength of our equity capital markets practice and cross-border capabilities, but also underscores the resilience and vibrancy of the Hong Kong IPO market, which continues to attract high-quality issuers.”
A DLA Piper team led by George Wu also advised on the Hong Kong IPO and H-share listing of Chifeng Jilong Gold Mining Company earlier this year, demonstrating the firm’s experience and knowledge in handling complex, cross-border equity transactions.